+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Naringin

BP0983
10236-47-2
98%
Biopurify
Aurantii fructus immaturus
Naringin exhibits antioxidant, anti-atherogenic, antiulcer, anti-hypocholesterolemic, anti-lipoperoxidative, and anti-hyperglycemia effects. Naringin reduces Ara-C-induced oxidative stress through both an inhibition of the generation of ROS production and an increase in antioxidant enzyme activities, it blocks apoptosis caused by Ara-C-induced oxidative stress, resulting in the inhibition of the cytotoxicity of Ara-C. Naringin attenuates epidermal growth factor (EGF)-induced MUC5AC secretion in A549 cells by suppressing the cooperative activities of MAPKs-AP-1 and IKKs-IκB-NF-κB signaling pathways. Naringin is a disaccharide derivative that is (S)-naringenin substituted by a 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. It has a role as a metabolite, an antineoplastic agent and an anti-inflammatory agent. It is a member of 4'-hydroxyflavanones, a (2S)-flavan-4-one, a neohesperidoside, a dihydroxyflavanone and a disaccharide derivative. It is functionally related to a (S)-naringenin.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0983-20mg 20mg
BP0983-1000mg 1000mg
BP0983-10g 10g
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

NFE2L2 HMGCR PPARG LDLR PPARA
BCL2 NFE2L2 MMP9 CASP3 SOD1 CCND1
BCL2 MMP9 CASP3
NFE2L2 PPARG SOD1 GPX1 HMOX1 PPARA

Product drug property prediction parameters

  • 225.0600

  • -.0049

  • -.0331

  • 4.5537

  • .4605

  • .2061

  • Low

  • 71.6719

  • 4.7383

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • Yes

  • No